San Francisco, 03 September 2025: The Report Mapping Catheters Market Size, Share & Trends Analysis Report By Technology (High-Density (HD) Mapping, Contact Force Sensing), By Indication (AF, AFL, VT), By End Use, By Region, And Segment Forecasts, 2025 - 2030

The global mapping catheters market size is expected to reach USD 4.96 billion by 2030, registering a CAGR of 8.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The primary factors driving the market are the rising cases of CVD, increasing arrhythmia (AF) incidence, technological advancements, and government initiatives. According to the (HRS) Heart Rhythm Society article published in August 2023, Atrial fibrillation (AFib) affects nearly 40 million individuals globally, including 6 million in the United States, making it the most prevalent cardiac arrhythmia. Almost one in four adults over 40 face the risk of developing AFib, often without recognizing early symptoms; the demand for timely and accurate diagnosis is skyrocketing. This rising need fuels the market, as these tools are essential for pinpointing arrhythmic sites and guiding targeted treatment, ultimately improving patient outcomes and reducing the risk of serious complications like stroke and heart failure.

Technological advancements in mapping systems are driving market growth. For instance, in June 2024, New tools like multielectrode basket catheters and devices capable of mapping cardiac arteries and epicardial veins enable detailed three-dimensional visualization of cardiac activation sequences, even during vacuum therapy. Additionally, computerized non-contact mapping systems transform electrophysiology by leveraging algorithms to reconstruct electrograms and create 3D isopotential maps without direct contact with the endocardial surface. These technological strides are complemented by remote monitoring and infection control improvements, which allow continuous heart rhythm assessment outside of hospital environments-enhancing patient safety, enabling timely therapeutic interventions, and minimizing risks associated with invasive procedures.

Moreover, the rising strategic initiatives by the market players fuel market growth. For instance, in May 2024, Biosense Webster, a Johnson & Johnson MedTech company and a global leader in treating cardiac arrhythmias, introduced CARTO 3 System Version 8, an advanced iteration of its 3D cardiac mapping platform. This upgrade enhances precision and procedural efficiency during catheter ablation treatments for arrhythmias like atrial fibrillation. Among the latest additions are the CARTO ELEVATE™ and CARTOSOUND™ FAM Modules, both developed to support electrophysiologists with improved accuracy, consistency, and workflow during complex ablation procedures.

The increasing prevalence of cardiac arrhythmias is one of the factors boosting market growth. Mapping catheters are specialized medical devices used during cardiac electrophysiology procedures to detect and record the heart’s electrical signals, helping doctors identify the source of abnormal heart rhythms. According to the Johnson & Johnson Services, Inc. article published in February 2024, more than 37.5 million people worldwide are currently affected by atrial fibrillation (AFib), and nearly one in four adults over the age of 40 are at risk of developing the condition during their lifetime. With AFib cases projected to increase by over 60% by 2050, the need for effective diagnostic and treatment solutions is becoming increasingly urgent. This growing demand is fueling the adoption of mapping catheters, essential for pinpointing abnormal electrical activity in the heart and guiding catheter ablation procedures.

Request sample report of Mapping Catheters Market@ https://www.grandviewresearch.com/industry-analysis/mapping-catheters-market-report/request/rs1

Increased cardiac procedures drive the growth of the market. According to the NCBI article published in August 2023, globally, an estimated 313 million cardiac procedures are performed yearly, a figure expected to rise significantly as access to cardiac care improves. Around 4.5 billion people lack access to essential cardiac surgical services, highlighting a substantial gap in treatment availability. Cardiac interventions are projected to increase as healthcare infrastructure develops, particularly in low- and middle-income regions. This growing procedural volume directly supports the rising demand for mapping catheters, vital tools for diagnosing and treating cardiac arrhythmias. These devices enable precise localization of electrical disturbances in the heart, which is critical in guiding ablation therapies and improving patient outcomes.

Advancements in cardiac mapping technology are driving the growth of the mapping catheter market. According to a National Heart, Lung, and Blood Institute article published in October 2023, one key innovation is the basket catheters, which have transformed how cardiac electrical activity is recorded. These specialized catheters feature multiple electrode sensors arranged in a spherical structure of flexible metallic filaments at the tip. Unlike conventional mapping techniques that collect electrical signals point by point, basket catheters enable the simultaneous recording of signals from multiple locations during a single heartbeat. This capability provides a comprehensive, high-resolution view of the heart’s electrical patterns, greatly enhancing the accuracy and efficiency of arrhythmia diagnosis and ablation procedures. The growing adoption of such advanced technologies is driving market growth.

Growing awareness of early detection of AF drives the growth of the market. According to the American Heart Association article published in November 2023, the guidelines released in 2023 by the American College of Cardiology (ACC), American College of Chest Physicians (ACCP), American Heart Association (AHA), and the Heart Rhythm Society (HRS) emphasize the need for heightened awareness and consistent screening for atrial fibrillation (AFib), particularly among older adults and other high-risk groups. With a strong focus on early detection through routine pulse assessments and electrocardiogram (ECG) screenings, these recommendations aim to facilitate timely diagnosis and intervention. This proactive approach supports the growing demand for advanced diagnostic tools, such as mapping catheters, which are instrumental in pinpointing abnormal electrical pathways within the heart. Early diagnosis becomes a clinical priority, and the use of mapping catheters is expected to increase, reinforcing their critical role in guiding effective AFib treatment and reducing the risk of severe complications like stroke.